Pharmafile Logo
Pharmafocus logo
Advanced Search
Dr Andreas Barner

Boehringer Ingelheim invests in Europe

December 24, 2015
Manufacturing and Production, Sales and Marketing Austria, Biberach, Boehringer Ingelheim, Vienna, biologicals, manufacturing, production

Boehringer Ingelheim will kick off its pharma investments in 2016 with a half a billion Euro outlay and plans to …

News
Pills image

OTC drugs market boosted by growing patient demand

December 24, 2015
Manufacturing and Production, Sales and Marketing GBI Research, OTC, generics, over the counter

Increasing pressures from customers, drug manufacturers and regulators to convert prescription medications to over-the-counter (OTC) non-prescription status is driving growth …

News
2016

Seven pharma trends for 2016

December 24, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing M&A, MA, biosimilars, collaborations, digital pharma, emerging markets, patient centricity, pharma, pricing

What will be the key industry trends in 2016?Pricing pressures

Feature
Celgene logo

Celgene settles Revlimid patent dispute

December 23, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Celgene, India, Natco, Revlimid, lenalidomide, patents

Celgene has settled its litigation with Natco Pharma, over the patents for Revlimid, opening the door to increased generic competition …

News
2000px-food_and_drug_administration_logo

FDA approves AstraZeneca’s gout drug Zurampic

December 23, 2015
Sales and Marketing AstraZeneca, FDA, Zurampic, gout, lensinurad

The US FDA has approved AstraZeneca’s Zurampic to treat high levels of uric acid in the blood. The drug is …

News
Janssen Velcade

NICE recommends Velcade for MCL, and three diabetes drugs

December 23, 2015
Sales and Marketing Forxiga, NICE, Velcade, invokana, jardiance, mantel cell lymphoma, mcl

NICE has published final guidance recommending Velcade (bortezomib) as a treatment for previously untreated mantle cell lymphoma (MCL).  In the …

News
melanoma cell

100 year old chemical could be the future of cancer treatment

December 23, 2015
Research and Development Cancer, PV-10, Peter Culpepper, Provectus, Rose Bengal, oncology

Peter Culpepper, chief operating officer at Provectus Biopharmaceuticals, explains the secrets of Rose Bengal, which has impressed in clinical trials …

Feature
Nucala

Researchers question price of GSK’s Nucala

December 23, 2015
Research and Development GSK, HEOR, ICER, Nucala, asthma, cost-effective, health economics, health economics outcomes research

GSK is charging up to four times more for its recently approved asthma drug Nucala than is justified by cost-effectiveness …

News
Bavarian Nordic logo

Janssen and Bavarian Nordic to collaborate on HPV vaccine

December 23, 2015
Research and Development Bavarian Nordic, HPV, Janssen, Vaccine, human papillomavirus, prime boost

Janssen has announced a new collaboration and license agreement with Bavarian Nordic to develop a vaccine for chronic Human Papillomavirus …

News
CT scan

Merck and Pfizer kick off Phase III avelumab cancer trials

December 23, 2015
Research and Development Merck, Pfizer, avelumab, ovarian cancer

Merck and Pfizer have announced the opening of trial sites for an international Phase III study of avelumab in patients …

News
Actelion building

Actelion ready to launch Uptravi after FDA approval

December 22, 2015
Research and Development, Sales and Marketing Actelion, FDA, Jean-Paul Clozel, Uptravi, pulmonary arterial hypertension, selexipag

Actelion says it is ready to launch Uptravi, its drug for pulmonary arterial hypertension in the US in January, after …

News
Flemming Ornskov

Shire moves to seal Baxalta deal with improved offer

December 22, 2015
Research and Development, Sales and Marketing Baxalta, Flemming Ornskov, Shire

Shire is set to sweeten its $30 billion bid for Baxalta by offering 40% of the total, or $12 billion, …

News
Gilenya

EMA adds warning label to Novartis’ MS treatment Gilenya

December 22, 2015
Manufacturing and Production EMA, European Medicines Agency, FDA, Novartis, PML, basal cell carcinoma, fingolimod, gilenya

Drug safety regulators in Europe have said they will add warnings to the label and prescribing information of Gilenya (fingolimod), …

News
ABPI

Pharma industry will pay £550m of NHS 2016 drugs bill

December 22, 2015
Manufacturing and Production ABPI, PPRS, Pharmaceutical Price Regulation Scheme

A new financial agreement announced this week as part of the Pharmaceutical Price Regulation Scheme (PPRS), will see the pharmaceutical …

News
Sun Pharma logo

Sun Pharma hit by FDA inspection warning

December 22, 2015
Manufacturing and Production FDA, Sun Pharma, manufacturing, production

Sun Pharma shares fell some 7% early this week after it emerged the Indian company received a warning letter from …

News

Former Cubist chief executive Michael Bonney to chair board at Alnylam

December 22, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Alnylam, David Pyott, michael bonney

Michael Bonney, current board member and former chief executive of Cubist Pharmaceuticals, has been appointed as chairman of Alnylam Pharmaceuticals …

Appointment
cdic_bangladesh_dhaka_day_12

Two billion people still lack medicines access. Is the industry doing enough?

December 22, 2015
Manufacturing and Production Access to Medicine Foundation, Access to Medicine Index, affordability, market access, medicines access, pricing

“We have a mission to encourage the pharmaceutical industry in improving access to medicine for the two billion people who …

Feature
sir_kent_woods

EMA management board chair stands down

December 21, 2015
Manufacturing and Production, Sales and Marketing EMA, European Medicines Agency, Sir Kent Woods

Sir Kent Woods will step down as chair of the board at the EMA from the end of December 2015. …

Appointment
Keytruda image

MSD’s Keytruda impresses in lung cancer chemotherapy trial

December 21, 2015
Manufacturing and Production, Research and Development MSD, PD-L1, docetaxel, keytruda, lung cancer, non small cell lung cancer, non-small cell lung cancer, pd-1, pembrolizumab

MSD’s Keytruda significantly improved overall survival (OS) compared to chemotherapy in people with lung cancer and PD-L1 expression, a trial …

News

Novartis completes purchase of rights to GSK drug for up to $1bn

December 21, 2015
Manufacturing and Production, Research and Development, Sales and Marketing

Novartis has completed the acquisition of all outstanding rights to Arzerra from GSK for up to $1.034 billion. The deal, …

News
The Gateway to Local Adoption Series

Latest content

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026